ZURA BIO LIMITED CLASS A ORDINARY SHARES
NASDAQ: ZURA (Zura Bio Limited)
Kemas kini terakhir: semalam, 11:43AM4.04
0.19 (4.94%)
| Penutupan Terdahulu | 3.85 |
| Jumlah Dagangan | 4,072,435 |
| Harga / Buku (P/B) | 2.08 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.770 |
| Nisbah Semasa (MRQ) | 8.14 |
| Aliran Tunai Operasi (OCF TTM) | -34.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.40 M |
| Pulangan Atas Aset (ROA TTM) | -31.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -55.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Zura Bio Limited | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.6 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -1.7 |
| Persekitaran Makro | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.55 |
|
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 29.16% |
| % Dimiliki oleh Institusi | 70.62% |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |